Security key
53566P109
Lineage Cell Therapeutics, Inc. - Common shares (LCTX)
CUSIP: 53566P109
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common shares
- Shares outstanding
- 250,425,788
- Total 13F shares
- 65,070,787
- Share change
- +496,364
- Total reported value
- $76,138,155
- Put/Call ratio
- 9.1%
- Price per share
- $1.17
- Number of holders
- 99
- Value change
- +$591,571
- Number of buys
- 46
- Number of sells
- 30
Report period
Q4 2022
Institutions
99
Top holders
10
LCTX full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Lineage Cell Therapeutics, Inc. SEC filings
Lineage Cell Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53566P109
Recent filing periods:
Top shareholders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
14%
|
34,935,485
|
$39,477,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
5,951,493
|
$6,726,000 | — | 30 Sep 2022 | |
| Defender Capital, LLC. |
13F
|
Company |
2.1%
|
5,184,035
|
$5,862,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.5%
|
3,704,387
|
$4,186,000 | — | 30 Sep 2022 | |
| Laurion Capital Management LP |
13F
|
Company |
0.95%
|
2,377,940
|
$2,687,000 | — | 30 Sep 2022 | |
| RAFFLES ASSOCIATES LP |
13F
|
Company |
0.83%
|
2,080,536
|
$2,351,000 | — | 30 Sep 2022 | |
| Prescott General Partners LLC |
13F
|
Company |
0.74%
|
1,851,851
|
$2,093,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
1,251,156
|
$1,413,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.42%
|
1,049,051
|
$1,185,000 | — | 30 Sep 2022 | |
| MAI Capital Management |
13F
|
Company |
0.21%
|
521,870
|
$590,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
506,313
|
$572,000 | — | 30 Sep 2022 | |
| Ergoteles LLC |
13F
|
Company |
0.2%
|
490,895
|
$555,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
440,096
|
$497,000 | — | 30 Sep 2022 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.13%
|
329,826
|
$373,000 | — | 30 Sep 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.12%
|
288,299
|
$326,000 | — | 30 Sep 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.1%
|
257,461
|
$291,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
241,666
|
$273,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
223,076
|
$252,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
220,063
|
$249,000 | — | 30 Sep 2022 | |
| LINCOLN NATIONAL CORP |
13F
|
Company |
0.09%
|
217,700
|
$246,000 | — | 30 Sep 2022 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.09%
|
215,000
|
$243,000 | — | 30 Sep 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.08%
|
189,320
|
$214,000 | — | 30 Sep 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.06%
|
140,000
|
$158,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
135,981
|
$154,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
122,796
|
$139,000 | — | 30 Sep 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.04%
|
103,322
|
$117,000 | — | 30 Sep 2022 | |
| Williams Jones Wealth Management, LLC. |
13F
|
Company |
0.04%
|
101,300
|
$114,000 | — | 30 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.04%
|
89,100
|
$101,000 | — | 30 Sep 2022 | |
| Fort Sheridan Advisors LLC |
13F
|
Company |
0.03%
|
83,931
|
$95,000 | — | 30 Sep 2022 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.03%
|
77,974
|
$88,000 | — | 30 Sep 2022 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
72,807
|
$82,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
70,785
|
$80,000 | — | 30 Sep 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.03%
|
69,260
|
$78,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
62,140
|
$70,000 | — | 30 Sep 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.02%
|
48,628
|
$55,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
48,464
|
$55,000 | — | 30 Sep 2022 | |
| Phoenix Financial Ltd. |
13F
|
Company |
0.02%
|
47,587
|
$55,000 | — | 30 Sep 2022 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.02%
|
45,623
|
$52,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
45,545
|
$52,000 | — | 30 Sep 2022 | |
| Beirne Wealth Consulting Services, LLC |
13F
|
Company |
0.02%
|
45,000
|
$51,000 | — | 30 Sep 2022 | |
| American Portfolios Advisors |
13F
|
Company |
0.02%
|
44,939
|
$50,781 | — | 30 Sep 2022 | |
| LMR Partners LLP |
13F
|
Company |
0.02%
|
44,733
|
$51,000 | — | 30 Sep 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
43,827
|
$50,000 | — | 30 Sep 2022 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.02%
|
42,990
|
$48,000 | — | 30 Sep 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
38,111
|
$43,000 | — | 30 Sep 2022 | |
| Strategic Wealth Investment Group, LLC |
13F
|
Company |
0.01%
|
37,008
|
$42,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
34,022
|
$38,000 | — | 30 Sep 2022 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.01%
|
33,500
|
$38,000 | — | 30 Sep 2022 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.01%
|
33,416
|
$37,000 | — | 30 Sep 2022 | |
| DOWLING & YAHNKE LLC |
13F
|
Company |
0.01%
|
32,263
|
$36,000 | — | 30 Sep 2022 |
Institutional Holders of Lineage Cell Therapeutics, Inc. - Common shares (LCTX) as of Q4 2022
As of 31 Dec 2022,
Lineage Cell Therapeutics, Inc. - Common shares (LCTX) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,070,787 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, VANGUARD GROUP INC, Defender Capital, LLC., BlackRock Inc., Laurion Capital Management LP, Prescott General Partners LLC, RAFFLES ASSOCIATES LP, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
88
Q4 2022 holders
99
Holder diff
11
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.